Clinical policy: Critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department

Annals of Emergency Medicine

Volumn 47, Issue 1, 2006, Pages 79-99

  Lukens, Thomas W ^a   Wolf, Stephen J ^a   Edlow, Jonathan A ^a   Shahabuddin, Samina ^a   Allen, Michael H ^a   Currier, Glenn W ^a   Jagoda, Andy S ^a  

^a AMERICAN COLLEGE OF EMERGENCY PHYSICIANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DROPERIDOL; FLUNITRAZEPAM; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; NEUROLEPTIC AGENT; OLANZAPINE; PROMETHAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; ZIPRASIDONE;

ACUTE DISEASE; AGITATION; CLINICAL TRIAL; COMPARATIVE STUDY; DISORIENTATION; DOSE TIME EFFECT RELATION; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SCREENING; DRUG TOLERABILITY; DYSPHORIA; EMERGENCY MEDICINE; EMERGENCY WARD; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH SURVEY; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; LABORATORY TEST; LONG TERM CARE; MENTAL DISEASE; MENTAL HEALTH; MENTAL PATIENT; METHODOLOGY; MONOTHERAPY; MOTOR DYSFUNCTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOLOGY; QT PROLONGATION; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SIDE EFFECT; TRANQUILIZING ACTIVITY; URINALYSIS; VITAL SIGN;

ADULT; ANTIPSYCHOTIC AGENTS; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; EMERGENCY SERVICES, PSYCHIATRIC; HUMANS; MEDICAL HISTORY TAKING; MENTAL DISORDERS; PHYSICAL EXAMINATION; PSYCHOMOTOR AGITATION; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 29444435925     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2005.10.002     Document Type: Review

References (65)

1. G.L. Larkin, C.A. Claassen, and J.A. Emond Trends in U.S. emergency department visits for mental health conditions, 1992-2001 Psychiatr Serv 56 2005 671 677
2. R.C. Hall, E.R. Gardner, and S.K. Stickney Physical illness manifesting as psychiatric disease. II. Analysis of a state hospital inpatient population Arch Gen Psychiatry 37 1980 989 995
3. R.C. Hall, E.R. Gardner, and M.K. Popkin Unrecognized physical illness prompting psychiatric admission: a prospective study Am J Psychiatry 138 1981 629 635
4. Y. Sheline, and C. Kehr Cost and utility of routine admission laboratory testing for psychiatric inpatients Gen Hosp Psychiatry 12 1990 329 334
5. L.M. Koran, Y. Sheline, and K. Imai Medical disorders among patients admitted to a public-sector psychiatric inpatient unit Psychiatr Serv 53 2002 1623 1625
6. K.B. Broderick, E.B. Lerner, and J.D. McCourt Emergency physician practices and requirements regarding the medical screening examination of psychiatric patients Acad Emerg Med 9 2002 88 92
7. L.J. Fochtmann Psychiatric perspectives on medical screening of psychiatric patients Acad Emerg Med 9 2002 963 964
8. L.S. Zun, R. Hernandez, and R. Thompson Comparison of EPs' and psychiatrists' laboratory assessment of psychiatric patients Am J Emerg Med 22 2004 175 180
9. R.J. Gregory, N.D. Nihalani, and E. Rodriguez Medical screening in the emergency department for psychiatric admissions: a procedural analysis Gen Hosp Psychiatry 26 2004 405 410
10. L.S. Zun, J.B. Leikin, and N.L. Stotland A tool for the emergency medicine evaluation of psychiatric patients Am J Emerg Med 14 1996 329 333
11. Massachusetts College of Emergency Physicians, Massachusetts Psychiatric Society. Consensus guidelines on the medical clearance exam for the evaluation and management of the psychiatric patient in the emergency department. 1999. Available at http://www.macep.org/practice_information/medical_clearance.htm, January 1, 2003.
12. J.S. Olshaker, B. Browne, and D.A. Jerrard Medical clearance and screening of psychiatric patients in the emergency department Acad Emerg Med 4 1997 124 128
13. American College of Emergency Physicians Clinical policy for the initial approach to patients presenting with altered mental status Ann Emerg Med 33 1999 251 281
14. D.L. Schriger, S.V. Cantrill, and C.S. Greene The origins, benefits, harms, and implications of emergency medicine clinical policies Ann Emerg Med 22 1993 597 602
15. T.J. Anfinson, and R.G. Kathol Screening laboratory evaluation in psychiatric patients: a review Gen Hosp Psychiatry 14 1992 248 257
16. P.L. Henneman, R. Mendoza, and R.J. Lewis Prospective evaluation of emergency department medical clearance Ann Emerg Med 24 1994 672 677
17. P.B. Kolman The value of laboratory investigations of elderly psychiatric patients J Clin Psychiatry 45 1984 112 116
18. J.G. Dolan, and A.I. Mushlin Routine laboratory testing for medical disorders in psychiatric inpatients Arch Intern Med 145 1985 2085 2088
19. B. Ferguson, and K. Dudleston Detection of physical disorder in newly admitted psychiatric patients Acta Psychiatr Scand 74 1986 485 489
20. A.J. White, and B. Barraclough Benefits and problems of routine laboratory investigations in adult psychiatric admissions Br J Psychiatry 155 1989 65 72
21. J.E. Tintinalli, F.W. Peacock, and M.A. Wright Emergency medical evaluation of psychiatric patients Ann Emerg Med 23 1994 859 862
22. C.S. Korn, G.W. Currier, and S.O. Henderson "Medical clearance" of psychiatric patients without medical complaints in the emergency department J Emerg Med 18 2000 173 176
23. M.J. Schiller, M. Shumway, and S.L. Batki Utility of routine drug screening in a psychiatric emergency setting Psychiatr Serv 51 2000 474 478
24. J.S. Eisen, M.L.A. Sivilotti, and K.U. Boyd Screening urine for drugs of abuse in the emergency department: do tests results affect physicians' patient care decisions Can J Emerg Med 6 2004 104 111
25. D.A. Yost Acute care for alcohol intoxication. Be prepared to consider clinical dilemmas Postgrad Med 112 2002 14 16 21-22, 25-26
26. G. Jayaram, J.S. Janofsky, and P.J. Fischer The emergency petition process in Maryland Bull Am Acad Psychiatry Law 18 1990 373 378
27. R.E. Breslow, B.I. Klinger, and B.J. Erickson Acute intoxication and substance abuse among patients presenting to a psychiatric emergency service Gen Hosp Psychiatry 18 1996 183 191
28. D. Dhossche, and J. Rubinstein Drug detection in a suburban psychiatric emergency room Ann Clin Psychiatry 8 1996 59 69
29. F.W. Lavoie Consent, involuntary treatment, and the use of force in an urban emergency department Ann Emerg Med 21 1992 25 32
30. M. Allen Managing the agitated psychotic patient: a reappraisal of the evidence J Clin Psychiatry 61 2000 11 20
31. R.H. McAllister-Williams, and I.N. Ferrier Rapid tranquillisation: time for a reappraisal of options for parenteral therapy Br J Psychiatry 180 2002 485 489
32. A. Yildiz, G.S. Sachs, and A. Turgay Pharmacological management of agitation in emergency settings Emerg Med J 20 2003 339 346
33. C. Salzman, D. Solomon, and E. Miyawaki Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior J Clin Psychiatry 52 1991 177 180
34. J. Battaglia, S. Moss, and J. Rush Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study Am J Emerg Med 15 1997 335 340
35. S. Foster, J. Kessel, and M.E. Berman Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting Int Clin Psychopharmacol 12 1997 175 179
36. E.S. Garza-Trevino, L.E. Hollister, and J.E. Overall Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation Am J Psychiatry 146 1989 1598 1601
37. G. Chouinard, L. Annable, and L. Turnier A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms Can J Psychiatry 38 1993 S114 S121
38. A. Dorevitch, N. Katz, and Z. Zemishlany Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior Am J Psychiatry 156 1999 142 144
39. J. Alexander, P. Tharyan, and C. Adams Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine Br J Psychiatry 185 2004 63 69
40. F. Nobay, B.C. Simon, and M.A. Levitt A prospective, double-blinded, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients Acad Emerg Med 11 2004 744 749
41. R. Mendoza, A.H. Djenderedjian, and J. Adams Midazolam in acute psychotic patients with hyperarousal J Clin Psychiatry 48 1987 291 292
42. M. Wyant, B.I. Diamond, and E. O'Neal The use of midazolam in acutely agitated psychiatric patients Psychopharmacol Bull 26 1990 126 129
43. TREC Collaborative Group Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine BMJ 327 2003 708 713
44. S.A. Bieniek, R.L. Ownby, and A. Penalver A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation Pharmacotherapy 18 1998 57 62
45. J.E. Clinton, S. Sterner, and Z. Stelmachers Haloperidol for sedation of disruptive emergency patients Ann Emerg Med 16 1987 319 322
46. R.J. Baldessarini, B.M. Cohen, and M.H. Teicher Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses Arch Gen Psychiatry 45 1988 79 91
47. H. Thomas Jr., E. Schwartz, and R. Petrilli Droperidol versus haloperidol for chemical restraint of agitated and combative patients Ann Emerg Med 21 1992 407 413
48. M. Resnick, and B.T. Burton Droperidol vs. haloperidol in the initial management of acutely agitated patients J Clin Psychiatry 45 1984 298 299
49. J.R. Richards, R.W. Derlet, and D.R. Duncan Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol J Emerg Med 16 1998 567 573
50. P.B. Chase, and M.H. Biros A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population Acad Emerg Med 9 2002 1402 1410
51. J.H. Shale, C.M. Shale, and W.D. Mastin A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients J Clin Psychiatry 64 2003 500 505
52. B.Z. Horowitz, K. Bizovi, and R. Moreno Droperidol- behind the black box warning Acad Emerg Med 9 2002 615 618
53. L.W. Kao, M.A. Kirk, and S.J. Evers Droperidol, QT prolongation, and sudden death: what is the evidence? Ann Emerg Med 41 2003 546 558
54. L. Citrome Atypical antipsychotics for acute agitation. New intramuscular options offer advantages Postgrad Med 112 2002 85 88 94-96
55. E.P. Harrigan, J.J. Miceli, and R. Anziano A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition J Clin Psychopharmacol 24 2004 62 69
56. D.G. Daniel, S.G. Potkin, and K.R. Reeves Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial Psychopharmacology 155 2001 128 134 (Berl)
57. M.D. Lesem, J.M. Zajecka, and R.H. Swift Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients J Clin Psychiatry 62 2001 12 18
58. S. Brook, J.V. Lucey, and K.P. Gunn Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group J Clin Psychiatry 61 2000 933 941
59. H. Preval, S.G. Klotz, and R. Southard Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study Gen Hosp Psychiatry 27 2005 140 144
60. A. Breier, K. Meehan, and M. Birkett A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia Arch Gen Psychiatry 59 2002 441 448
61. P. Wright, M. Birkett, and S.R. David Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia Am J Psychiatry 158 2001 1149 1151
62. K. Meehan, F. Zhang, and S. David A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania J Clin Psychopharmacol 21 2001 389 397
63. K.M. Meehan, H. Wang, and S.R. David Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia Neuropsychopharmacology 26 2002 494 504
64. FDA Psychopharmacological Drugs Advisory Committee Addendum to Briefing Document for Zyprexa® Intramuscular (Olanzapine for Injection) 2001 Eli Lilly and Company
65. G.W. Currier, J.C. Chou, and D. Feifel Acute treatment of psychotic agitation: a randomized CANcomparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam J Clin Psychiatry 65 2004 386 394